Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Objective It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease. Methods Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections. Results Serum concentrati...

Full description

Saved in:
Bibliographic Details
Published inInflammation research Vol. 58; no. 8; pp. 503 - 512
Main Authors Frol’ová, Lenka, Smetana, Karel, Borovská, Dana, Kitanovičová, Andrea, Klimešová, Klára, Janatková, Ivana, Malíčková, Karin, Lukáš, Milan, Drastich, Pavel, Beneš, Zdeněk, Tučková, Ludmila, Manning, Joachim C., André, Sabine, Gabius, Hans-Joachim, Tlaskalová-Hogenová, Helena
Format Journal Article
LanguageEnglish
Published Basel SP Birkhäuser Verlag Basel 01.08.2009
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1023-3830
1420-908X
1420-908X
DOI10.1007/s00011-009-0016-8

Cover

More Information
Summary:Objective It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease. Methods Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections. Results Serum concentrations were significantly increased in specimen of patients with active and remission-stage ulcerative colitis and Crohn’s disease, associated with emerging positivity of CD14 + cells. Conclusion Enhanced concentration of galectin-3 in serum reflects presence of disease and points to its involvement in the pathogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1023-3830
1420-908X
1420-908X
DOI:10.1007/s00011-009-0016-8